CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
Clinical trials for CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY trials appear
Sign up with your email to follow new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for debilitating nerve disease
Disease control CompletedThis study tested an experimental drug called SAR445088 in adults with CIDP, a rare condition that causes progressive weakness and numbness. The main goal was to see if the drug could control the disease and prevent relapses in different groups of patients, including those who do…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
Phase: PHASE2 • Sponsor: Bioverativ, a Sanofi company • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Blood test breakthrough could simplify treatment for debilitating nerve diseases
Knowledge-focused CompletedThis study aimed to see if simple blood tests taken right after starting a standard IVIg treatment could predict the best long-term dose for patients with CIDP or MMN. These are chronic nerve disorders that cause weakness and require ongoing IVIg treatment. Researchers followed 2…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
Sponsor: Walton Centre NHS Foundation Trust • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC